INS and COVID-19: However, Chen et al found that COVID-19 patients taking insulin, although they presented with significantly different inflammatory markers (higher CRP, procalcitonin and erythrocyte sedimentation rate), they did not have an overall difference in severity than to patients not taking insulin [36].